Cronos Group Inc (NASDAQ: CRON) shares are trading higher by 21% to $2.06 over the trailing five sessions, driven by the strong performance of the cannabis sector. Cannabis stocks have risen over the past week on news that the Department of Health and Human Services (HHS) proposed reclassifying marijuana to a lower-risk drug category.

See Also: Weed Stocks Skyrocket, Could There Be More Upside? Analyst Draws …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.